# Progress Note 05 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frederick Law Olmsted (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI022-SYN-TD
- Date: 1895-09-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nathan Calder, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit)

## Chief complaint

Subsequent annual wellness visit; no new complaints. **S**

## History of present illness

Mr. Olmsted is a 73-year-old man with mild dementia of undetermined type who returns with his caregiver for his subsequent annual wellness visit, six weeks after his three-month dementia review. He answered the health risk assessment himself, with his caregiver reading the questions and adding what he could not recall. His cold in July cleared in two weeks, and he has had no further night-time confusion since the antihistamine was stopped. He takes donepezil 10 mg each morning, given by his caregiver from a weekly organizer, with no nausea, diarrhea, dizziness, or vivid dreams. He no longer drives. He walks most days with company and goes to an adult day program twice a week, which he enjoys for the gardens. He has had no falls, emergency visits, or hospital stays this year. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Context | Health risk assessment answered by the patient with caregiver help because of dementia |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Donepezil 10 mg daily from a weekly organizer; no over-the-counter medicines since the cold |
| Active conditions | Mild dementia of undetermined type, CDR 1 |
| Functional status | Independent in basic activities of daily living; needs help with finances, medicines, and travel |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| How completed | Answered by the patient with his caregiver reading the questions and adding what he could not recall |
| Self-rated health | Good, in his words |
| Psychosocial | Lives at home with family; adult day program twice a week; misses his work but enjoys the gardens and visitors |
| Tobacco | Never used tobacco |
| Alcohol | None since the first visit (AUDIT-C 0) |
| Physical activity | Walks 30 to 45 minutes most days with company |
| Nutrition | Three regular meals; weight stable over the past three months |
| Sleep | Sleeps through most nights; no sleep medicines |
| Activities of daily living | Independent in bathing, dressing, toileting, and eating |
| Instrumental activities of daily living | Caregiver manages medicines, bill paying, and transport, with his agreement |
| Home safety | No firearms in the home; medicines kept locked; night lights in place; smoke detectors working |
| Falls | No falls this year |
| Hearing and vision | No hearing concern; reading glasses; no eye examination in the past two years |
| Memory | Known mild dementia; his caregiver notices no change since the spring |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable over three months; no fever or new fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | Cold resolved; no hearing difficulty in conversation |
| Cardiovascular | Negative | No chest pain, fainting, or lightheadedness on donepezil |
| Respiratory | Negative | Cough resolved; no breathlessness |
| Gastrointestinal | Negative | No nausea, diarrhea, or loss of appetite on donepezil |
| Genitourinary | Negative | Gets up once a night to pass urine; no incontinence |
| Musculoskeletal | Negative | No joint pain or falls |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Positive | Known memory loss, unchanged by his caregiver's account; no night-time confusion since the antihistamine was stopped |
| Psychiatric | Negative | Mood fair to good; no hallucinations or agitation; PHQ-2 score 1 |
| Endocrine | Negative | No thirst or frequent urination |

12 systems reviewed. **S**

## Current medications

- Donepezil 10 mg oral tablet, one tablet by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/74 mmHg; pulse 60 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 71 kg; BMI 23.2 kg/m². All vital signs are synthetic.

PHQ-2: 1; AUDIT-C: 0; Total cholesterol: 196 mg/dL; HDL cholesterol: 54 mg/dL; LDL cholesterol: 118 mg/dL; Triglycerides: 120 mg/dL. All results are synthetic.

## Immunizations given today

- High-dose influenza vaccine, 1895-1896 season **S**
- Pneumococcal conjugate vaccine PCV20 **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Alert, courteous, and well groomed; weight 71.0 kg, BMI 23.2 |
| Eyes | Pupils equal and reactive; near vision 20/30 with reading glasses |
| Ears | Canals clear; whispered-voice test passed in both ears |
| Neck | No thyroid enlargement or nodes; no carotid bruits |
| Cardiovascular | Regular rhythm at 60 per minute; no murmur; no edema; blood pressure 128/74 mmHg |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses or aortic pulsation |
| Musculoskeletal | Timed Up and Go 11 seconds; rises from a chair without using his arms |
| Neurological | Oriented to person and place, not to date; repeats a question once; no focal weakness; normal gait. Cognition assessed by direct observation and the established diagnosis |
| Psychiatric | Pleasant and engaged; no agitation |
| Skin | Weathered skin on the face and hands; no suspicious lesions |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed and a written prevention plan given to him and his caregiver. Depression and alcohol screens are negative. Cognition was assessed by direct observation in established mild dementia; the MoCA stays on the yearly dementia schedule. Ten-year cardiovascular risk is about 18 percent by the pooled cohort equations, from age alone, with no diabetes, hypertension, dyslipidemia, or smoking. **S**
   - Next annual wellness visit in one year.
2. **Mild dementia, type undetermined** (F03.A0). Stable by observation and his caregiver's account. Heart rate 60 on donepezil 10 mg, without fainting or gastrointestinal effects. **S**
   - Continue donepezil 10 mg each morning.
   - Six-month dementia review in about six weeks.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | High-dose vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| COVID-19 vaccine, this season | Due | Recommended at his age; his caregiver will arrange it at the pharmacy |
| RSV vaccine | Not indicated | Recommended at 75 and older, and from 50 with conditions that raise risk; he has none. Review at 75 |
| Tetanus, diphtheria, and pertussis booster | Due | No dose on record in the past ten years; to be given with the second zoster dose |
| Depression screening | Completed today | PHQ-2 score 1; PHQ-9 continues at the dementia reviews |
| Alcohol misuse screening | Completed today | AUDIT-C score 0 |
| Cognitive assessment | Completed today | Direct observation in established mild dementia; MoCA 19 at diagnosis, repeated yearly on the CMID schedule |
| Falls prevention | Completed today | Timed Up and Go 11 seconds; no falls; daily walking continues |
| Hearing | Completed today | Whispered-voice test passed in both ears; hearing loss would worsen cognition, so it will be rechecked yearly |
| Eye examination | Due | No eye examination in the past two years; his caregiver will book one |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 196, HDL 54, LDL 118, triglycerides 120 mg/dL. Ten-year risk about 18 percent from age alone, without diabetes, hypertension, dyslipidemia, or smoking, so the USPSTF criteria for a statin are not met. A statin was discussed; he prefers no new daily medicine, and his caregiver agrees |
| Diabetes screening | Not indicated | Recommended for overweight adults 35 to 70; BMI 23.2, and glucose was normal in May |
| Colorectal cancer screening | Ordered | No screening on record in the past ten years; at 73 with mild dementia and good health, he chose a fecal immunochemical test, and a kit was given to his caregiver today |
| Prostate cancer screening | Not indicated | PSA screening is not recommended at 70 and older |
| Hepatitis C screening | Ordered | One-time screening recommended for adults 18 to 79; no result on record; drawn with today's blood tests with his consent |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Advance care planning | Up to date | Health care agent named and his wishes recorded six weeks ago; reviewed today without change |

## Advance care planning

The advance care planning completed six weeks ago was reviewed with him and his caregiver. His health care agent remains the same and is recorded in the chart, not named here. He confirmed that what matters most to him is staying at home among gardens and trees for as long as it is safe, and being told the truth about his condition. No decisions were changed. The plan will be revisited at the yearly dementia review and at any change in stage. **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026), Aether Forge
- Medicare Wellness Visits (Medicare Learning Network) (2026), Centers for Medicare & Medicaid Services
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Six-month dementia review in about six weeks. Second zoster dose and the Tdap booster in two to six months. Return the stool test kit within two weeks; the hepatitis C result will be sent by letter. Next annual wellness visit in one year. **S**
- Next scheduled visit 1895-10-27: six-month dementia review. **S**
